PRESS RELEASE published on 01/30/2023 at 14:30, 3 years 2 months ago Jaguar Health Engages Former FDA Gastroenterology Division Deputy Director Andrew Mulberg, M.D. to Bolster Company's Regulatory Expertise
PRESS RELEASE published on 01/27/2023 at 22:15, 3 years 2 months ago Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRESS RELEASE published on 01/26/2023 at 14:30, 3 years 2 months ago Jaguar Health Provides Updates Regarding Company's Focus on Rare and Orphan Disease Indications in the U.S. & Europe
PRESS RELEASE published on 01/25/2023 at 14:30, 3 years 2 months ago Jaguar Health Announces Completion of Key Milestone in Process of Establishing Indena S.p.A. as a Reliable Approved Crofelemer Manufacturer
PRESS RELEASE published on 01/23/2023 at 14:30, 3 years 3 months ago Jaguar Health Announces Establishment of Board of Directors for Newly Formed Joint Venture Magdalena Biosciences
PRESS RELEASE published on 01/20/2023 at 18:45, 3 years 3 months ago Jaguar Health Reports Voting Results from January 2023 Special Meeting of Stockholders
PRESS RELEASE published on 01/20/2023 at 14:30, 3 years 3 months ago Jaguar Health to Present at Lytham Partners Investor Select Conference on January 31st
PRESS RELEASE published on 01/12/2023 at 01:10, 3 years 3 months ago REMINDER: Jaguar Health to Hold Investor Webcast Thursday, January 12th at 10:30 AM EST to Highlight Unmet Medical Need of Cancer Therapy-related Diarrhea and Jaguar’s Mental Health Entheogen Therapeutics Initiative (ETI) to Discover Novel Therapies Der
PRESS RELEASE published on 01/11/2023 at 14:30, 3 years 3 months ago Sandra M. Swain, MD, FACP, FASCO Joins Jaguar Health's Scientific Advisory Board
PRESS RELEASE published on 01/10/2023 at 14:45, 3 years 3 months ago Jaguar Health to Hold Investor Webcast Thursday, January 12th at 10:30 AM EST to Highlight Unmet Medical Need of Cancer Therapy-related Diarrhea and Jaguar's Mental Health Entheogen Therapeutics Initiative (ETI) to Discover Novel Therapies Derived from Ps
Published on 04/24/2026 at 15:00, 6 hours 38 minutes ago Norsemont Reports Significant Copper, Lead & Zinc Values in Three Choquelimpie Drill Holes
Published on 04/24/2026 at 15:00, 6 hours 38 minutes ago First Canadian Graphite Appoints Scott Kelly As Chief Financial Officer
Published on 04/24/2026 at 14:30, 7 hours 8 minutes ago Jaguar Health Announces Acceptance of two Late-Breaking Abstracts for Liquid Oral Crofelemer Treatment of Intestinal Failure in Pediatric Patients at the European Society for Pediatric Gastroenterology, Hepatology & Nutrition (ESPGHAN)
Published on 04/24/2026 at 14:00, 7 hours 38 minutes ago Datametrex Expands Patent Monetization Strategy Adding Quantum-Resilient Encryption Technologies
Published on 04/24/2026 at 13:30, 8 hours 8 minutes ago Alset AI Announces Closing of Second Tranche of Loan Transaction of up to $3 Million
Published on 04/24/2026 at 18:30, 3 hours 8 minutes ago EUROPLASMA: Tirage de 400 obligations convertibles en actions nouvelles pour un montant nominal de 2M€
Published on 04/24/2026 at 18:12, 3 hours 25 minutes ago EQS-Adhoc: clearvise AG reviews dividend proposal in line with its dividend strategy and postpones Annual General Meeting
Published on 04/24/2026 at 18:07, 3 hours 30 minutes ago DEAG sets new records for revenue and earnings in financial year 2025 – excellently positioned for long-term growth
Published on 04/24/2026 at 18:05, 3 hours 32 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/24/2026 at 18:48, 2 hours 49 minutes ago Laboratoires Euromedis - Communiqué résultat 2025
Published on 04/24/2026 at 18:00, 3 hours 38 minutes ago SMTPC - Communiqué sur la mise à disposition du Rapport annuel 2025
Published on 04/24/2026 at 17:45, 3 hours 53 minutes ago Imerys-04-2026-information-share-capital-and-voting-rights-as-of-31-March-2026
